Indianapolis, Indiana, United States
NCT Number: NCT00691327
Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants
Safety and effectiveness of Natrelle™ Cohesive Round Silicone-Filled Breast Implants in women undergoing primary reconstruction or revision of existing breast implants.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Females of any age for which breast reconstruction is considered appropriate (Patients under 18 years old require parental/legal guardian consent to participate.
- Females seeking revision augmentation or revision reconstruction, where problems exist
- Have any of the following conditions or situations present:
- Post mastectomy surgical removal of the breast for cancer or other disease;
- Post trauma or post surgery where there was total or partial removal of the breast resulting in significant deformity;
- Severe ptosis requiring reconstruction;
- Any congenital or acquired discrepancy in breast size such as to represent a significant physical deformity.
- Adequate tissue available to cover implants.
- Saline-filled implants are not an appropriate choice.
Exclusion criteria
- Advanced fibrocystic disease considered to be premalignant without accompanying subcutaneous mastectomy.
- Existing carcinoma of the breast, without mastectomy.
- Abscess of infection in the body at the time of enrollment.
- Pregnant or nursing.
- Have any disease, including uncontrolled diabetes, which is clinically known to impact wound healing ability.
- Show tissue characteristics which are clinically incompatible with mammaplasty.
- Have, or under treatment for any condition which, in the opinion of the surgeon, may constitute an unwarranted surgical risk.
- Are not willing to undergo further surgery for revision, if medically required.
- Diagnosis of lupus or scleroderma.
Treatment and study plan
Natrelle(TM) Silicone-Filled Breast Implants
DeviceBreast implant surgery
Primary outcomes
-
Local Complications
Time frame: 5 years
By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts
Secondary outcomes
-
Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale
Time frame: 5 years
Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied
Sponsors and collaborators
Lead sponsor
Allergan Medical
Industry
Registry information
Important dates
- Study start
- 1997
- Primary completion
- 2012
- Study completion
- 2012
- First posted
- Jun 5, 2008
- Registry last updated
- Oct 13, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
NIR Device for Assessment of Skin Flap Perfusion in Breast Surgery: A Pilot Interventional Study
NCT07680296
Breast Cancer, Breast Diseases
Pisa, Italy
View Trial DetailsSafety and Performance of Motiva® Sizers
NCT06274736
Breast Augmentation, Breast Implant; Complications
Coyol, Alajuela Province, Costa Rica
View Trial DetailsThe Effect of Nurse-Led Coaching Program on Self-Care Agency and Quality of Life in Reconstructed Breast Cancer Patients
NCT07355946
Breast Reconstruction
Ankara, Turkey (Türkiye)
View Trial DetailsCiNPWT Using in Mastectomy Wound Care After DIEP Flaps for Breast Reconstruction
NCT07546968
Breast Reconstruction, Closed-Incision Negative Pressure Therapy
Chiayi City, Taiwan
View Trial Details